Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-07-19
2005-07-19
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S381000, C514S397000, C514S406000, C514S427000, C546S121000, C546S276400, C548S250000, C548S314100, C548S364100, C548S517000, C548S518000, C548S565000, C548S567000, C548S569000
Reexamination Certificate
active
06919368
ABSTRACT:
The present application describes modulators of CCR3 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
REFERENCES:
patent: 2993897 (1961-07-01), Shapiro et al.
patent: 3133061 (1964-05-01), Kirchner et al.
patent: 3461120 (1969-08-01), Zenitz et al.
patent: 5668151 (1997-09-01), Poindexter et al.
patent: 5688955 (1997-11-01), Kruse et al.
patent: 6331541 (2001-12-01), Ko et al.
patent: 6331545 (2001-12-01), Ko et al.
patent: 6441001 (2002-08-01), Watson et al.
patent: 6444686 (2002-09-01), Ko et al.
patent: 350309 (1990-01-01), None
patent: 0747357 (1996-12-01), None
patent: 0903349 (1999-03-01), None
patent: 1554549 (1979-10-01), None
patent: WO 9422846 (1994-10-01), None
patent: WO 9427991 (1994-12-01), None
patent: WO 9519344 (1995-07-01), None
patent: WO 9717954 (1997-05-01), None
patent: WO 9722597 (1997-07-01), None
patent: WO 9727752 (1997-08-01), None
patent: WO 97/28799 (1997-08-01), None
patent: WO 9738665 (1997-10-01), None
patent: WO 9825604 (1998-06-01), None
patent: WO 9825617 (1998-06-01), None
patent: WO 9831364 (1998-07-01), None
patent: WO 9320099 (1998-10-01), None
patent: WO 9961421 (1999-12-01), None
patent: WO 9964393 (1999-12-01), None
patent: WO 9967204 (1999-12-01), None
patent: WO 99/67204 (1999-12-01), None
patent: WO 0035451 (2000-06-01), None
patent: WO 0035453 (2000-06-01), None
patent: WO 0035454 (2000-06-01), None
patent: WO 0043384 (2000-07-01), None
patent: WO 0076512 (2000-12-01), None
patent: WO 0198270 (2001-12-01), None
Cohen et al. “Cuytokine function: a study in biologic diversity” CA 125:31527 (1996).
see copending case.
Alker et al., “Preparation of 1-aralkyl-3-(aralkoxy)piperidines as muscarinc areceptor antagonists”. EP 350309. Chem. Abstract No. 112:235186.
Kim et al., “Migration and proliferation of guinea pig and human airway epithelial cells in response to tachkykinins”,Am. J. Physiol., 1995, vol. 269, 1, 1, pp. L119-L126, Chem. Abstract No. 123:133809.
Kraneveld et al., “Airway hyperresponsiveness: first eosinophils and then neuropeptides”,Int. J. Immunopharmacoo., 1998, vol. 19, 9/10. pp. 517-527, Chem. Abstract No. 129:107602.
Johnson et al., “Synthesis of Amine Derivatives of Phencyclidine”,American Chemical Society. 1981, pp. 2048-2054, vol. 46, No. 10.
Johnson et al., Chemdraw Structure.J. Org. Chemistry, 1981, pp. 2049-2054, vol. 46, No. 10.
Grell et al., Repaglinide and Related Hypoglycemic Benzoic Acid Derivatives.J. Med. Chem., 1998, pp. 5219-5246, vol 41.
Decosta et al., “Synthesis and Evaluation of N-Substituted cis-N-Methyl-2-(1-Pyrrolidinyl) Cyclohexylamines as Hight Affinity Receptor Ligands, Identification of a New Class of Highly Potent and Selective Receptor Probes”,J. Med. Chem., 1990, pp. 3100-3110, vol. 33.
Rubini et al., “Synthesis of isoteric methylene=oxy pseudodipeptide analogues as novel amide bond surrogate units”,Tetrahedren. v.42(21)pp. 6039-6045 (1986).
Delorme et al., “Preparation of 1-N-substituted aminomethyl-4-(or8)guanidinomethylbenzene useful in management of pain”, PCT WO 99 67204. Chem. Abstract No. 132:49083.
Kruse et al., “Kappa agonist compounds and formulations (acylpiperazines and analogs) and pharmaceutical formulations thereof”, J.S. 5.688.955. Chem. Abstract No 128:34783.
Delucca George V.
Duncia John V.
Kim Ui Tae
Ko Soo S.
Wacker Dean A.
Bristol-Myers Squibb Pharma Company
Chang Celia
VanAtten Mary
LandOfFree
N-ureidoalkyl-piperidines as modulators of chemokine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-ureidoalkyl-piperidines as modulators of chemokine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-ureidoalkyl-piperidines as modulators of chemokine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3433307